LXEO (LXEO) Stock Price & Analysis
LXEO (LXEO) rose 1.03% to USD 4.89 as of September 8, 2026 at 04:15 UTC, according to Nexqual real-time market data.
LXEO last closed at USD 4.89; the session ranged USD 4.76–4.99 on volume of 296,442 shares. Market capitalization is —, with a 52-week range of USD 3.99–10.99 (NGM). Source: Nexqual, September 8, 2026 at 04:15 UTC.
Key Statistics (as of September 8, 2026 at 04:15 UTC)
| Price | USD 4.89 |
|---|---|
| Change | ▲ 1.03% (up) |
| Previous Close | USD 4.89 |
| Open | USD 4.89 |
| Day Range | USD 4.76 – 4.99 |
| 52-Week Range | USD 3.99 – 10.99 |
| Volume | 296,442 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (LXEO)
Nexqual's technical model rates LXEO "BUY" based on 4 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 04:15 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 51.46 (neutral) |
| vs SMA50 | Above (USD 4.74) |
| MACD | 0.03 (positive) |
From LXEO's Latest SEC 10-K Filing (filed 2026-03-30)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MLYS | Mineralys Therapeutics, Inc. | USD 28.21 | ▼ 2.86% |
| NGNE | Neurogene Inc. | USD 38.6 | ▲ 0.63% |
| LRMR | Larimar Therapeutics, Inc. | USD 3.83 | ▼ 1.03% |
| KYTX | Kyverna Therapeutics, Inc. | USD 8.25 | ▼ 4.24% |
| PEPG | PepGen Inc. | USD 3.11 | ▼ 2.2% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 04:15 UTC. This page is informational and not investment advice.